Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population

In the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), women in the multimodal (MMS) arm had a serum CA125 test (first-line), with those at increased risk, having repeat CA125/ultrasound (second-line test). CA125 was interpreted using the "Risk of Ovarian Cancer Algori...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cancer research 2018-10, Vol.24 (19), p.4726-4733
Hauptverfasser: Blyuss, Oleg, Burnell, Matthew, Ryan, Andy, Gentry-Maharaj, Aleksandra, Mariño, Inés P, Kalsi, Jatinderpal, Manchanda, Ranjit, Timms, John F, Parmar, Mahesh, Skates, Steven J, Jacobs, Ian, Zaikin, Alexey, Menon, Usha
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4733
container_issue 19
container_start_page 4726
container_title Clinical cancer research
container_volume 24
creator Blyuss, Oleg
Burnell, Matthew
Ryan, Andy
Gentry-Maharaj, Aleksandra
Mariño, Inés P
Kalsi, Jatinderpal
Manchanda, Ranjit
Timms, John F
Parmar, Mahesh
Skates, Steven J
Jacobs, Ian
Zaikin, Alexey
Menon, Usha
description In the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), women in the multimodal (MMS) arm had a serum CA125 test (first-line), with those at increased risk, having repeat CA125/ultrasound (second-line test). CA125 was interpreted using the "Risk of Ovarian Cancer Algorithm" (ROCA). We report on performance of other serial algorithms and a single CA125 threshold as a first-line screen in the UKCTOCS dataset. 50,083 post-menopausal women who attended 346,806 MMS screens were randomly split into training and validation sets, following stratification into cases (ovarian/tubal/peritoneal cancers) and controls. The two longitudinal algorithms, a new serial algorithm, method of mean trends (MMT) and the parametric empirical Bayes (PEB) were trained in the training set and tested in the blinded validation set and the performance characteristics, including that of a single CA125 threshold, were compared. The area under receiver operator curve (AUC) was significantly higher ( = 0.01) for MMT (0.921) compared with CA125 single threshold (0.884). At a specificity of 89.5%, sensitivities for MMT [86.5%; 95% confidence interval (CI), 78.4-91.9] and PEB (88.5%; 95% CI, 80.6-93.4) were similar to that reported for ROCA (sensitivity 87.1%; specificity 87.6%; AUC 0.915) and significantly higher than the single CA125 threshold (73.1%; 95% CI, 63.6-80.8). These findings from the largest available serial CA125 dataset in the general population provide definitive evidence that longitudinal algorithms are significantly superior to simple cutoff values for ovarian cancer screening. Use of these newer algorithms requires incorporation into a multimodal strategy. The results highlight the importance of incorporating serial change in biomarker levels in cancer screening/early detection strategies. .
doi_str_mv 10.1158/1078-0432.CCR-18-0208
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6171745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2084914357</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-98e166e697225ce367c9aee525a4c7ce57329540bec90d76506cb72e8fd0fe6a3</originalsourceid><addsrcrecordid>eNpVkVtr3DAQhUVpaNJNfkKLHvviVKOr_VJYTJMWFhJ6eRZa7XhXxZa2kh3ov6-WXGhBoAOa881Bh5B3wK4BVPsRmGkbJgW_7vtvDVTNWfuKXIBSphFcq9dVP8-ck7el_GIMJDD5hpwLxlrZCnFBUp-mo8uhpEjTQDcp7sO87EJ0I-3XwBVdj_uUw3yYCnX10JuQy9xsQkT63WfESIeU6d1DhbhIexc9ZhoinQ9IbzFirqT7dFxGN4cUL8nZ4MaCV0_3ivy8-fyj_9Js7m6_9utN4yXA3HQtgtaoO8O58ii08Z1DVFw56Y1HZQTvlGRb9B3bGa2Y9lvDsR12bEDtxIp8euQel-2EO49xrkHsMYfJ5T82uWD_f4nhYPfpwWowYKSqgA9PgJx-L1hmO4XicRxdxLQUW39bdiBFTbIi6nHU51RKxuFlDTB7KsueirCnImwty0LV1V597__N-OJ6bkf8BZdfkRs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2084914357</pqid></control><display><type>article</type><title>Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Blyuss, Oleg ; Burnell, Matthew ; Ryan, Andy ; Gentry-Maharaj, Aleksandra ; Mariño, Inés P ; Kalsi, Jatinderpal ; Manchanda, Ranjit ; Timms, John F ; Parmar, Mahesh ; Skates, Steven J ; Jacobs, Ian ; Zaikin, Alexey ; Menon, Usha</creator><creatorcontrib>Blyuss, Oleg ; Burnell, Matthew ; Ryan, Andy ; Gentry-Maharaj, Aleksandra ; Mariño, Inés P ; Kalsi, Jatinderpal ; Manchanda, Ranjit ; Timms, John F ; Parmar, Mahesh ; Skates, Steven J ; Jacobs, Ian ; Zaikin, Alexey ; Menon, Usha</creatorcontrib><description>In the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), women in the multimodal (MMS) arm had a serum CA125 test (first-line), with those at increased risk, having repeat CA125/ultrasound (second-line test). CA125 was interpreted using the "Risk of Ovarian Cancer Algorithm" (ROCA). We report on performance of other serial algorithms and a single CA125 threshold as a first-line screen in the UKCTOCS dataset. 50,083 post-menopausal women who attended 346,806 MMS screens were randomly split into training and validation sets, following stratification into cases (ovarian/tubal/peritoneal cancers) and controls. The two longitudinal algorithms, a new serial algorithm, method of mean trends (MMT) and the parametric empirical Bayes (PEB) were trained in the training set and tested in the blinded validation set and the performance characteristics, including that of a single CA125 threshold, were compared. The area under receiver operator curve (AUC) was significantly higher ( = 0.01) for MMT (0.921) compared with CA125 single threshold (0.884). At a specificity of 89.5%, sensitivities for MMT [86.5%; 95% confidence interval (CI), 78.4-91.9] and PEB (88.5%; 95% CI, 80.6-93.4) were similar to that reported for ROCA (sensitivity 87.1%; specificity 87.6%; AUC 0.915) and significantly higher than the single CA125 threshold (73.1%; 95% CI, 63.6-80.8). These findings from the largest available serial CA125 dataset in the general population provide definitive evidence that longitudinal algorithms are significantly superior to simple cutoff values for ovarian cancer screening. Use of these newer algorithms requires incorporation into a multimodal strategy. The results highlight the importance of incorporating serial change in biomarker levels in cancer screening/early detection strategies. .</description><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.CCR-18-0208</identifier><identifier>PMID: 30084833</identifier><language>eng</language><publisher>United States</publisher><subject>Aged ; Algorithms ; Biomarkers, Tumor - blood ; CA-125 Antigen - blood ; Early Detection of Cancer ; Female ; Humans ; Longitudinal Studies ; Membrane Proteins - blood ; Middle Aged ; Ovarian Neoplasms - blood ; Ovarian Neoplasms - epidemiology ; Ovarian Neoplasms - pathology ; Risk Factors ; Ultrasonography ; United Kingdom</subject><ispartof>Clinical cancer research, 2018-10, Vol.24 (19), p.4726-4733</ispartof><rights>2018 American Association for Cancer Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-98e166e697225ce367c9aee525a4c7ce57329540bec90d76506cb72e8fd0fe6a3</citedby><cites>FETCH-LOGICAL-c411t-98e166e697225ce367c9aee525a4c7ce57329540bec90d76506cb72e8fd0fe6a3</cites><orcidid>0000-0003-3381-5057 ; 0000-0002-0194-6389 ; 0000-0003-0166-1700 ; 0000-0003-3708-1732</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3356,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30084833$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Blyuss, Oleg</creatorcontrib><creatorcontrib>Burnell, Matthew</creatorcontrib><creatorcontrib>Ryan, Andy</creatorcontrib><creatorcontrib>Gentry-Maharaj, Aleksandra</creatorcontrib><creatorcontrib>Mariño, Inés P</creatorcontrib><creatorcontrib>Kalsi, Jatinderpal</creatorcontrib><creatorcontrib>Manchanda, Ranjit</creatorcontrib><creatorcontrib>Timms, John F</creatorcontrib><creatorcontrib>Parmar, Mahesh</creatorcontrib><creatorcontrib>Skates, Steven J</creatorcontrib><creatorcontrib>Jacobs, Ian</creatorcontrib><creatorcontrib>Zaikin, Alexey</creatorcontrib><creatorcontrib>Menon, Usha</creatorcontrib><title>Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><description>In the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), women in the multimodal (MMS) arm had a serum CA125 test (first-line), with those at increased risk, having repeat CA125/ultrasound (second-line test). CA125 was interpreted using the "Risk of Ovarian Cancer Algorithm" (ROCA). We report on performance of other serial algorithms and a single CA125 threshold as a first-line screen in the UKCTOCS dataset. 50,083 post-menopausal women who attended 346,806 MMS screens were randomly split into training and validation sets, following stratification into cases (ovarian/tubal/peritoneal cancers) and controls. The two longitudinal algorithms, a new serial algorithm, method of mean trends (MMT) and the parametric empirical Bayes (PEB) were trained in the training set and tested in the blinded validation set and the performance characteristics, including that of a single CA125 threshold, were compared. The area under receiver operator curve (AUC) was significantly higher ( = 0.01) for MMT (0.921) compared with CA125 single threshold (0.884). At a specificity of 89.5%, sensitivities for MMT [86.5%; 95% confidence interval (CI), 78.4-91.9] and PEB (88.5%; 95% CI, 80.6-93.4) were similar to that reported for ROCA (sensitivity 87.1%; specificity 87.6%; AUC 0.915) and significantly higher than the single CA125 threshold (73.1%; 95% CI, 63.6-80.8). These findings from the largest available serial CA125 dataset in the general population provide definitive evidence that longitudinal algorithms are significantly superior to simple cutoff values for ovarian cancer screening. Use of these newer algorithms requires incorporation into a multimodal strategy. The results highlight the importance of incorporating serial change in biomarker levels in cancer screening/early detection strategies. .</description><subject>Aged</subject><subject>Algorithms</subject><subject>Biomarkers, Tumor - blood</subject><subject>CA-125 Antigen - blood</subject><subject>Early Detection of Cancer</subject><subject>Female</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Membrane Proteins - blood</subject><subject>Middle Aged</subject><subject>Ovarian Neoplasms - blood</subject><subject>Ovarian Neoplasms - epidemiology</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Risk Factors</subject><subject>Ultrasonography</subject><subject>United Kingdom</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkVtr3DAQhUVpaNJNfkKLHvviVKOr_VJYTJMWFhJ6eRZa7XhXxZa2kh3ov6-WXGhBoAOa881Bh5B3wK4BVPsRmGkbJgW_7vtvDVTNWfuKXIBSphFcq9dVP8-ck7el_GIMJDD5hpwLxlrZCnFBUp-mo8uhpEjTQDcp7sO87EJ0I-3XwBVdj_uUw3yYCnX10JuQy9xsQkT63WfESIeU6d1DhbhIexc9ZhoinQ9IbzFirqT7dFxGN4cUL8nZ4MaCV0_3ivy8-fyj_9Js7m6_9utN4yXA3HQtgtaoO8O58ii08Z1DVFw56Y1HZQTvlGRb9B3bGa2Y9lvDsR12bEDtxIp8euQel-2EO49xrkHsMYfJ5T82uWD_f4nhYPfpwWowYKSqgA9PgJx-L1hmO4XicRxdxLQUW39bdiBFTbIi6nHU51RKxuFlDTB7KsueirCnImwty0LV1V597__N-OJ6bkf8BZdfkRs</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Blyuss, Oleg</creator><creator>Burnell, Matthew</creator><creator>Ryan, Andy</creator><creator>Gentry-Maharaj, Aleksandra</creator><creator>Mariño, Inés P</creator><creator>Kalsi, Jatinderpal</creator><creator>Manchanda, Ranjit</creator><creator>Timms, John F</creator><creator>Parmar, Mahesh</creator><creator>Skates, Steven J</creator><creator>Jacobs, Ian</creator><creator>Zaikin, Alexey</creator><creator>Menon, Usha</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3381-5057</orcidid><orcidid>https://orcid.org/0000-0002-0194-6389</orcidid><orcidid>https://orcid.org/0000-0003-0166-1700</orcidid><orcidid>https://orcid.org/0000-0003-3708-1732</orcidid></search><sort><creationdate>20181001</creationdate><title>Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population</title><author>Blyuss, Oleg ; Burnell, Matthew ; Ryan, Andy ; Gentry-Maharaj, Aleksandra ; Mariño, Inés P ; Kalsi, Jatinderpal ; Manchanda, Ranjit ; Timms, John F ; Parmar, Mahesh ; Skates, Steven J ; Jacobs, Ian ; Zaikin, Alexey ; Menon, Usha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-98e166e697225ce367c9aee525a4c7ce57329540bec90d76506cb72e8fd0fe6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Algorithms</topic><topic>Biomarkers, Tumor - blood</topic><topic>CA-125 Antigen - blood</topic><topic>Early Detection of Cancer</topic><topic>Female</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Membrane Proteins - blood</topic><topic>Middle Aged</topic><topic>Ovarian Neoplasms - blood</topic><topic>Ovarian Neoplasms - epidemiology</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Risk Factors</topic><topic>Ultrasonography</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blyuss, Oleg</creatorcontrib><creatorcontrib>Burnell, Matthew</creatorcontrib><creatorcontrib>Ryan, Andy</creatorcontrib><creatorcontrib>Gentry-Maharaj, Aleksandra</creatorcontrib><creatorcontrib>Mariño, Inés P</creatorcontrib><creatorcontrib>Kalsi, Jatinderpal</creatorcontrib><creatorcontrib>Manchanda, Ranjit</creatorcontrib><creatorcontrib>Timms, John F</creatorcontrib><creatorcontrib>Parmar, Mahesh</creatorcontrib><creatorcontrib>Skates, Steven J</creatorcontrib><creatorcontrib>Jacobs, Ian</creatorcontrib><creatorcontrib>Zaikin, Alexey</creatorcontrib><creatorcontrib>Menon, Usha</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blyuss, Oleg</au><au>Burnell, Matthew</au><au>Ryan, Andy</au><au>Gentry-Maharaj, Aleksandra</au><au>Mariño, Inés P</au><au>Kalsi, Jatinderpal</au><au>Manchanda, Ranjit</au><au>Timms, John F</au><au>Parmar, Mahesh</au><au>Skates, Steven J</au><au>Jacobs, Ian</au><au>Zaikin, Alexey</au><au>Menon, Usha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>24</volume><issue>19</issue><spage>4726</spage><epage>4733</epage><pages>4726-4733</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><abstract>In the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), women in the multimodal (MMS) arm had a serum CA125 test (first-line), with those at increased risk, having repeat CA125/ultrasound (second-line test). CA125 was interpreted using the "Risk of Ovarian Cancer Algorithm" (ROCA). We report on performance of other serial algorithms and a single CA125 threshold as a first-line screen in the UKCTOCS dataset. 50,083 post-menopausal women who attended 346,806 MMS screens were randomly split into training and validation sets, following stratification into cases (ovarian/tubal/peritoneal cancers) and controls. The two longitudinal algorithms, a new serial algorithm, method of mean trends (MMT) and the parametric empirical Bayes (PEB) were trained in the training set and tested in the blinded validation set and the performance characteristics, including that of a single CA125 threshold, were compared. The area under receiver operator curve (AUC) was significantly higher ( = 0.01) for MMT (0.921) compared with CA125 single threshold (0.884). At a specificity of 89.5%, sensitivities for MMT [86.5%; 95% confidence interval (CI), 78.4-91.9] and PEB (88.5%; 95% CI, 80.6-93.4) were similar to that reported for ROCA (sensitivity 87.1%; specificity 87.6%; AUC 0.915) and significantly higher than the single CA125 threshold (73.1%; 95% CI, 63.6-80.8). These findings from the largest available serial CA125 dataset in the general population provide definitive evidence that longitudinal algorithms are significantly superior to simple cutoff values for ovarian cancer screening. Use of these newer algorithms requires incorporation into a multimodal strategy. The results highlight the importance of incorporating serial change in biomarker levels in cancer screening/early detection strategies. .</abstract><cop>United States</cop><pmid>30084833</pmid><doi>10.1158/1078-0432.CCR-18-0208</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3381-5057</orcidid><orcidid>https://orcid.org/0000-0002-0194-6389</orcidid><orcidid>https://orcid.org/0000-0003-0166-1700</orcidid><orcidid>https://orcid.org/0000-0003-3708-1732</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1078-0432
ispartof Clinical cancer research, 2018-10, Vol.24 (19), p.4726-4733
issn 1078-0432
1557-3265
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6171745
source MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Aged
Algorithms
Biomarkers, Tumor - blood
CA-125 Antigen - blood
Early Detection of Cancer
Female
Humans
Longitudinal Studies
Membrane Proteins - blood
Middle Aged
Ovarian Neoplasms - blood
Ovarian Neoplasms - epidemiology
Ovarian Neoplasms - pathology
Risk Factors
Ultrasonography
United Kingdom
title Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T16%3A59%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Longitudinal%20CA125%20Algorithms%20as%20a%20First-Line%20Screen%20for%20Ovarian%20Cancer%20in%20the%20General%20Population&rft.jtitle=Clinical%20cancer%20research&rft.au=Blyuss,%20Oleg&rft.date=2018-10-01&rft.volume=24&rft.issue=19&rft.spage=4726&rft.epage=4733&rft.pages=4726-4733&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.CCR-18-0208&rft_dat=%3Cproquest_pubme%3E2084914357%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2084914357&rft_id=info:pmid/30084833&rfr_iscdi=true